Institution
Johns Hopkins University School of Medicine
Healthcare•Baltimore, Maryland, United States•
About: Johns Hopkins University School of Medicine is a healthcare organization based out in Baltimore, Maryland, United States. It is known for research contribution in the topics: Population & Cancer. The organization has 44277 authors who have published 79222 publications receiving 4788882 citations.
Topics: Population, Cancer, Transplantation, Prostate cancer, Poison control
Papers published on a yearly basis
Papers
More filters
••
TL;DR: A factor analysis of the 90-item version of the Hopkins Symptom Checklist, performed on the pretreatment self-ratings of nonpsychotic outpatients with symptoms of depression and anxiety, revealed the presence of 8 clinically meaningful factors.
585 citations
••
TL;DR: Recent progress is reviewed and questions related to adult mammalian neural stem cells that also apply to other somatic stem cells are focused on.
585 citations
••
Trinity College, Dublin1, National Institutes of Health2, University of Pennsylvania3, University College London4, Indiana University – Purdue University Indianapolis5, University of Birmingham6, Johns Hopkins University School of Medicine7, Icahn School of Medicine at Mount Sinai8, University of Chicago9, University of Helsinki10, University of Antwerp11, University of California, San Diego12, Garvan Institute of Medical Research13, University of New South Wales14, Laval University15, University of Utah16, University of Edinburgh17, Washington University in St. Louis18, University of California, Los Angeles19, University of Bonn20, Dalhousie University21, University of Ottawa22, McGill University23, Université libre de Bruxelles24, Umeå University25, University of California, Irvine26, Macquarie University27, University of Texas Health Science Center at San Antonio28, University of California, San Francisco29, University of Costa Rica30, Aarhus University Hospital31, Odense University Hospital32, University of Geneva33, Hacettepe University34
TL;DR: The present results for the very narrow model are promising but suggest that more and larger data sets are needed to support linkage, as well as suggest that linkage might be detected in certain populations or subsets of pedigrees.
Abstract: Genome scans of bipolar disorder (BPD) have not produced consistent evidence for linkage. The rank-based genome scan meta-analysis (GSMA) method was applied to 18 BPD genome scan data sets in an effort to identify regions with significant support for linkage in the combined data. The two primary analyses considered available linkage data for "very narrow" (i.e., BP-I and schizoaffective disorder-BP) and "narrow" (i.e., adding BP-II disorder) disease models, with the ranks weighted for sample size. A "broad" model (i.e., adding recurrent major depression) and unweighted analyses were also performed. No region achieved genomewide statistical significance by several simulation-based criteria. The most significant P values (<.01) were observed on chromosomes 9p22.3-21.1 (very narrow), 10q11.21-22.1 (very narrow), and 14q24.1-32.12 (narrow). Nominally significant P values were observed in adjacent bins on chromosomes 9p and 18p-q, across all three disease models on chromosomes 14q and 18p-q, and across two models on chromosome 8q. Relatively few BPD pedigrees have been studied under narrow disease models relative to the schizophrenia GSMA data set, which produced more significant results. There was no overlap of the highest-ranked regions for the two disorders. The present results for the very narrow model are promising but suggest that more and larger data sets are needed. Alternatively, linkage might be detected in certain populations or subsets of pedigrees. The narrow and broad data sets had considerable power, according to simulation studies, but did not produce more highly significant evidence for linkage. We note that meta-analysis can sometimes provide support for linkage but cannot disprove linkage in any candidate region.
585 citations
••
TL;DR: The authors tested the hypothesis that HIF‐1 expression correlates with progression and angiogenesis in brain tumors and found no evidence that it correlates with disease progression.
Abstract: BACKGROUND
Hypoxia inducible factor-1 (HIF-1) plays a critical role in angiogenesis during vascular development. The authors tested the hypothesis that HIF-1 expression correlates with progression and angiogenesis in brain tumors.
METHODS
The authors investigated the expression of the HIF-1α and HIF-1β subunits in human glioma cell lines and brain tumor tissues using Western blot analysis and immunohistochemistry.
RESULTS
In glioblastomas multiforme (GBMs), HIF-1α primarily was localized in pseudopalisading cells around areas of necrosis and in tumor cells infiltrating the brain at the tumor margin. In contrast, HIF-1α was expressed in stromal cells throughout hemangioblastomas (HBs). Like HIF-1α, HIF-1β was most highly expressed in high grade tumors but was expressed more widely than HIF-1α, including cells away from necrotic zones. In the brains of mice injected with Glioma 261 cells, a pattern of HIF-1α expression identical to that observed in human GBMs was noted.
CONCLUSIONS
In GBMs, the heterogeneous pattern of HIF-1α expression appears to be determined at least in part by tissue oxygenation, whereas in HBs the homogeneous expression of HIF-1α may be driven by an oncogenic rather than a physiologic stimulus. Cancer 2000;88:2606–18. © 2000 American Cancer Society.
585 citations
••
TL;DR: Two pieces of software are reported, Tablemaker and Ballgown, that bridge the gap between transcriptome assembly and fast, flexible differential expression analysis in RNA-seq data.
Abstract: We have built a statistical package called Ballgown for estimating differential expression of genes, transcripts, or exons from RNA sequencing experiments. Ballgown is designed to work with the popular Cufflinks transcript assembly software and uses well-motivated statistical methods to provide estimates of changes in expression. It permits statistical analysis at the transcript level for a wide variety of experimental designs, allows adjustment for confounders, and handles studies with continuous covariates. Ballgown provides improved statistical significance estimates as compared to the Cuffdiff differential expression tool included with Cufflinks. We demonstrate the flexibility of the Ballgown package by re-analyzing 667 samples from the GEUVADIS study to identify transcript-level eQTLs and identify non-linear artifacts in transcript data. Our package is freely available from: https://github.com/alyssafrazee/ballgown
584 citations
Authors
Showing all 44754 results
Name | H-index | Papers | Citations |
---|---|---|---|
Robert Langer | 281 | 2324 | 326306 |
Bert Vogelstein | 247 | 757 | 332094 |
Solomon H. Snyder | 232 | 1222 | 200444 |
Steven A. Rosenberg | 218 | 1204 | 199262 |
Kenneth W. Kinzler | 215 | 640 | 243944 |
Hagop M. Kantarjian | 204 | 3708 | 210208 |
Mark P. Mattson | 200 | 980 | 138033 |
Stuart H. Orkin | 186 | 715 | 112182 |
Paul G. Richardson | 183 | 1533 | 155912 |
Aaron R. Folsom | 181 | 1118 | 134044 |
Gonçalo R. Abecasis | 179 | 595 | 230323 |
Jie Zhang | 178 | 4857 | 221720 |
Daniel R. Weinberger | 177 | 879 | 128450 |
David Baker | 173 | 1226 | 109377 |
Eliezer Masliah | 170 | 982 | 127818 |